People

Paul Enever

Co-founded the CanepaHealthcare/Evidity investment firm with AlejandroSanchez in2014. Former McKinseyPartner with twelveyears advising biopharma,medtech,hospitals andhealthcareservices; earlier SandozR&D andMITbiotechnologyresearch. Holds a Rensselaer chemicalengineeringBS and UniversityofMinnesota chemicalengineeringPhD focusedonwoundhealing/tissueengineering. OwnEviditybio lists Augmedics,MagnoliaMedical andPoseidonMedical boards and formerCardiva,DuneMedical andStandardMolecular boards; no uncoordinatednew outsidecompanyroles orpersonalchecks are inferred. Current2026Eckuitydirectory independentlylists himasPartner and foundertransitionpostexplicitlydescribes joiningEckuity; legacyEvidityrole notexclusivecurrentoperatingclaim. Paul Enever is partner at Eckuity Capital. Co-founded Evidity in 2014 and joined Eckuity as a partner in 2026. His existing Evidity biography, portrait and institutional affiliations are preserved.

Roles

EvidityHealthCapital

Co-Founder / Partner (published Evidity roster; 2026 Eckuity transition)

Current
Current